Showing results (131-140 of 185) with videos related to

Sort By:
Pageof 19
The Pediatric Infectious Disease Journal|March 10, 2026
Invasive Meningococcal Disease in Australian Children 2016-2022: A Multicenter, Prospective Surveillance Study of Serogroup Distribution and Clinical Presentation in the Meningococcal Vaccine EraMaya Wositzky, Jennie Louise, Natascha D'Angelo, et al.
Vaccine|March 6, 2018
Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised studyClare L Cutland, Terry Nolan, Scott A Halperin, et al.
Vaccine|January 17, 2007
Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infantsStephanie T Yerkovich, Julie Rowe, Peter Richmond, et al.
JAMA|December 23, 2009
Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trialTerry Nolan, Jodie McVernon, Maryanne Skeljo, et al.
The Medical Journal of Australia|November 13, 2014
The safety of seasonal influenza vaccines in Australian children in 2013Nicholas J Wood, Chris C Blyth, Gabriela A Willis, et al.
The Pediatric Infectious Disease Journal|October 20, 2012
Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in Hib-primed toddlersRobert Booy, Peter Richmond, Terry Nolan, et al.
The Pediatric Infectious Disease Journal|December 20, 2012
Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in AustraliaHelen S Marshall, Peter McIntyre, Peter Richmond, et al.
Clinical and Vaccine Immunology : CVI|December 26, 2014
An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trialNina Wressnigg, Maikel V W van der Velden, Daniel Portsmouth, et al.
The Journal of Infection|August 14, 2016
Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 studyHelen Marshall, Michael Nissen, Peter Richmond, et al.
Vaccine|February 25, 2023
Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants: A phase III study (PNEU-PED-EU-2)Thomas Benfield, Mika Rämet, Piero Valentini, et al.
Pageof 19